Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Central adaptation after optic neuritis: Is the whole greater than the sum of its parts?
Neuroimmune semaphorin 4A as a drug and drug target for asthma.
Clinical and demographic factors affecting disease severity in patients with multiple sclerosis.
Prevalence of neurological conditions across the continuum of care based on interRAI assessments.
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis.
Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job).
Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy.
[Effect of LINGO-1 gene silencing on movement function of EAE mice].
Urinary tract infections in multiple sclerosis.
Origins of oligodendrocytes in the cerebellum, whose development is controlled by the transcription factor, Sox9.
pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin.
Vitamin D as a protective factor in multiple sclerosis.
Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review.
Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis.
Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
Stage-Specific Regulation of Oligodendrocyte Development by Wnt/β-Catenin Signaling.
Hsp70 regulates immune response in experimental autoimmune encephalomyelitis.
MRI pattern in asymptomatic natalizumab-associated PML.
Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study.
Effective communication at the point of multiple sclerosis diagnosis.
Pages
« first
‹ previous
…
441
442
443
444
445
446
447
448
449
…
next ›
last »